LAFAYETTE, NY / ACCESSWIRE / August 15, 2022 / Ichor Life Sciences, a preclinical contract research organization, today announced a $1.5 million investment in MitoChem Therapeutics. Based in ...
Ichor Holdings (ICHR) came out with quarterly earnings of $0.70 per share, missing the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.76 per share a year ago. These ...
Jeff Andreson, the Chief Executive Officer of Ichor Holdings, Ltd. (NASDAQ:ICHR), has sold 42,800 ordinary shares of the company, according to a recent filing with the Securities and Exchange ...
AI data center buildout and SME rebound should drive renewed demand for Ichor’s fluid delivery subsystems, positioning it for a cyclical upside. 1Q25 results signal potential bottoming, with +21% YoY ...
Investing.com - B.Riley has downgraded Ichor Holdings (NASDAQ:ICHR) from Buy to Neutral and reduced its price target to $18.00 from $30.00, citing concerns about gross margin performance. The stock, ...
Ichor Holdings, Ltd. (NASDAQ: ICHR), a leader in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment, today announced ...
LAFAYETTE, N.Y.--(BUSINESS WIRE)--Auctus Biologics, Inc., a new portfolio company of Ichor Therapeutics, Inc., announced today the closure of $1.5MM in seed funding. The company will develop RPtag, a ...
FREMONT, Calif.--(BUSINESS WIRE)--Ichor Holdings, Ltd. (NASDAQ: ICHR), a leader in the design, engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment, ...
Aug. 04, 2020 2:09 AM ETIchor Holdings, Ltd. (ICHR) StockBy: SA News Team 8 Comments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results